These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33392931)

  • 1. The Government's Involvement in Prenatal Drug Testing May Be Toxic.
    Nguemeni Tiako MJ; Sweeney L
    Matern Child Health J; 2022 Apr; 26(4):761-763. PubMed ID: 33392931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Newborn Drug Testing After Implementation of Question-Based Screening for Prenatal Substance Use.
    Soos A; Plegue M; Darwiche A; Oshman L; Frank CJ
    Obstet Gynecol; 2024 Aug; 144(2):233-240. PubMed ID: 38843536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Policies That Treat Prenatal Substance Use As Child Abuse Or Neglect Fail To Achieve Their Intended Goals.
    Atkins DN; Durrance CP
    Health Aff (Millwood); 2020 May; 39(5):756-763. PubMed ID: 32364867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining Child Protection: Addressing the Harms of Structural Racism and Punitive Approaches for Birthing People, Dyads, and Families Affected by Substance Use.
    Wakeman SE; Bryant A; Harrison N
    Obstet Gynecol; 2022 Aug; 140(2):167-173. PubMed ID: 35852265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive health and blurred professional boundaries.
    Chavkin W; Breitbart V
    Womens Health Issues; 1996; 6(2):89-96. PubMed ID: 8932462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Implementation of State and Federal Child Welfare Laws Related to Drug Use in Pregnancy.
    McCOURT AD; White SA; Bandara S; Schall T; Goodman DJ; Patel E; McGINTY EE
    Milbank Q; 2022 Dec; 100(4):1076-1120. PubMed ID: 36510665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punitive legal responses to prenatal drug use in the United States: A survey of state policies and systematic review of their public health impacts.
    Bruzelius E; Underhill K; Askari MS; Kajeepeta S; Bates L; Prins SJ; Jarlenski M; Martins SS
    Int J Drug Policy; 2024 Apr; 126():104380. PubMed ID: 38484529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U.S. State rates of newborns reported to child protection at birth for prenatal substance exposure.
    Rebbe R; Sieger ML; Reddy J; Prindle J
    Int J Drug Policy; 2024 Aug; 130():104527. PubMed ID: 39059078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn drug testing practices in Iowa birthing hospitals.
    Wood KE; Smith P; Krasowski MD
    J Neonatal Perinatal Med; 2017; 10(4):445-450. PubMed ID: 29286931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal substance abuse and human subjects research: are privacy protections adequate?
    Marshall MF; Menikoff J; Paltrow LM
    Ment Retard Dev Disabil Res Rev; 2003; 9(1):54-9. PubMed ID: 12587139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal substance exposure diagnosed at birth and infant involvement with child protective services.
    Prindle JJ; Hammond I; Putnam-Hornstein E
    Child Abuse Negl; 2018 Feb; 76():75-83. PubMed ID: 29078100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of racial disparities in urine drug testing after implementation of a standardized testing policy for pregnant patients.
    Peterson JA; Koelper NC; Curley C; Sonalkar SR; James AT
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100913. PubMed ID: 36870533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of State Laws Giving Pregnant People Priority Access to Drug Treatment Programs in the Context of Coexisting Punitive Laws.
    White SA; McCourt A; Bandara S; Goodman DJ; Patel E; McGinty EE
    Womens Health Issues; 2023; 33(2):117-125. PubMed ID: 36272928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals.
    Shetty C; Oshman L; Costa A; Waidley V; Madlambayan E; Joassaint M; McCabe K; Townsel C; Wu JP; Frank CJ; Chandanabhumma PP
    Ann Fam Med; 2024; 22(4):271-278. PubMed ID: 39038971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
    Jarlenski M; Hogan C; Bogen DL; Chang JC; Bodnar LM; Van Nostrand E
    Womens Health Issues; 2017; 27(3):264-270. PubMed ID: 28129942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide practices for screening and reporting prenatal cocaine abuse: a survey of teaching programs.
    Pelham TL; DeJong AR
    Child Abuse Negl; 1992; 16(5):763-70. PubMed ID: 1393735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Implementation Evaluation of the Comprehensive Addiction Recovery Act (CARA) Policy in New Mexico.
    Sharp N; Fuchs J; Drake A
    Matern Child Health J; 2023 Dec; 27(Suppl 1):113-121. PubMed ID: 37851151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018.
    Patel E; Bandara S; Saloner B; Stuart EA; Goodman D; Terplan M; McCourt A; White S; McGinty EE
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100419. PubMed ID: 34116233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.